人参皂苷Rg1激活腺苷酸激活蛋白激酶抑制体外诱导的非酒精性脂肪性肝细胞模型脂质沉积

肖晴; 黄文祥; 章述军; 阳成; 李佳俊; 赵金秋; 高月

doi:10.16016/j.1000-5404.201901074

您当前的位置：

首页 >

文章列表页 >

人参皂苷Rg1激活腺苷酸激活蛋白激酶抑制体外诱导的非酒精性脂肪性肝细胞模型脂质沉积

基础医学 | 更新时间：2026-01-09

- 人参皂苷Rg1激活腺苷酸激活蛋白激酶抑制体外诱导的非酒精性脂肪性肝细胞模型脂质沉积
- Ginsenoside Rg1 activates AMPK to inhibit lipid deposition in a cell model of non-alcoholic fatty liver disease
- 第三军医大学学报 2019年41卷第14期页码：1343-1349
- 作者机构：
  
  400016 重庆，重庆医科大学附属第一医院感染科
- 作者简介：
  
  [黄文祥，E-mail:wenxiang_huang@163.comHUANG Wenxiang, E-mail:wenxiang_huang@163.com
- 基金信息：
  
  重庆市科委基础科学与前沿技术研究重点项目(CSTC2015jcyjBX0079)
- DOI：10.16016/j.1000-5404.201901074
  中图分类号： R282.71;R285.5;R575.505
- 收稿：2019-01-09，
  
  修回：2019-03-11，
  
  纸质出版：2019-07-30
- 稿件说明：
移动端阅览
肖晴, 黄文祥, 章述军, 等. 人参皂苷Rg1激活腺苷酸激活蛋白激酶抑制体外诱导的非酒精性脂肪性肝细胞模型脂质沉积[J]. 第三军医大学学报, 2019,41(14):1343-1349.

Qing XIAO, Wenxiang HUANG, Shujun ZHANG, et al. Ginsenoside Rg1 activates AMPK to inhibit lipid deposition in a cell model of non-alcoholic fatty liver disease[J]. Journal of Third Military Medical University, 2019, 41(14): 1343-1349.
肖晴, 黄文祥, 章述军, 等. 人参皂苷Rg1激活腺苷酸激活蛋白激酶抑制体外诱导的非酒精性脂肪性肝细胞模型脂质沉积[J]. 第三军医大学学报, 2019,41(14):1343-1349. DOI： 10.16016/j.1000-5404.201901074.

Qing XIAO, Wenxiang HUANG, Shujun ZHANG, et al. Ginsenoside Rg1 activates AMPK to inhibit lipid deposition in a cell model of non-alcoholic fatty liver disease[J]. Journal of Third Military Medical University, 2019, 41(14): 1343-1349. DOI： 10.16016/j.1000-5404.201901074.

摘要

目的

探讨人参皂苷Rg1对非酒精性脂肪性肝细胞模型脂质沉积的作用及其分子机制。

方法

用0.25 mmol/L棕榈酸处理HepG2细胞24 h构建非酒精性脂肪肝细胞模型；加或不加10 μmol/L AMPK抑制剂(Compound C，CC)预处理1 h，再使用40 μg/mL人参皂苷Rg1或5 μmol/L二甲双胍处理6 h。微量法检测细胞内甘油三酯(triglyceride

TG)含量；油红O染色观察脂滴聚集情况。RT-qPCR及Western blot检测腺苷酸激活蛋白激酶(AMP-activated protein kinase，AMPK)通路相关基因及蛋白的变化。

结果

与对照组比较，模型组细胞内TG、油红O染色吸光度增加(

＜0.05)。Rg1能减少TG及油红O染色吸光度(

＜0.05)。Rg1能增加被棕榈酸抑制的腺苷酸激活蛋白激酶(AMPK)和乙酰辅酶A羧化酶(acetyl-CoA carboxylase，ACC)的磷酸化，下调胆固醇结合调节元件蛋白(sterol regulatory element binding proteins-1c，SREBP-1C)和脂肪酸合成酶(fatty acid synthase，FAS)的表达(

＜0.05)，CC预处理能显著逆转Rg1的改善作用及其对AMPK通路的影响(

＜0.05)。

结论

Rg1可通过调控腺苷酸激活蛋白激酶通路减少非酒精性脂肪性肝病细胞模型脂质沉积。

Abstract

Objective

To investigate the effect of ginsenoside Rg1 on lipid deposition in a cell model of non-alcoholic fatty liver disease (NAFLD) and explore the molecular mechanism.

Methods

HepG2 cells were treated with 0.25 mmol/L palmitic acid for 24 h to induce changes mimicking NAFLD

followed by treatment with 40 μg/mL ginsenoside Rg1 or 5 μmol/L metformin for 6 h with or without pretreatment with 10 μmol/L Compound C (CC

an AMPK inhibitor) for 1 h. The level of triglyceride (TG) in the cells was detected using a micromethod

and the accumulation of lipid droplets was observed using Oil Red O staining. RT-qPCR and Western blotting were employed to detect the alterations in the mRNA and protein expression of the key genes related to the AMPK pathway.

Results

Compared with the control cells

the cell model of NAFLD showed significantly increased intracellular TG level and lipid droplet accumulation (

0.05)

which were both reduced obviously after Rg1 treatment (

0.05). Rg1 significantly abolished palmitic acid-induced inhibition of phosphorylation of intracellular AMPK and acetyl-CoA carboxylase (ACC)

and down-regulated the expression of sterol regulatory element-binding protein-1c and fatty acid synthase (

0.05). Pretreatment with CC significantly antagonized the effects of Rg1 on intracellular TG

lipid deposition and AMPK pathway in palmitic acid-ind

uced cells (

0.05).

Conclusion

Ginsenoside Rg1 can ameliorate lipid deposition in the cell model of NAFLD by activating the AMPK pathway.

关键词

Keywords

references

ANDRONESCU C I, PURCAREA M R, BABES P A. Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications[J]. J Med Life, 2018, 11(1): 20-23.

DAY C P, JAMES O F.Steatohepatitis: a tale of two "hits"?[J]. Gastroenterology, 1998, 114(4): 842-845.

KHAN R, BRIL F, KEN C S, et al . Modulation of insulin resistance in NAFLD[J ] . Hepatology, 2018. DOI: 10.1002/hep.30429

ZHANG H A, YANG X Y, XIAO Y F. AMPKα1 overexpression alleviates the hepatocyte model of nonalcoholic fatty liver disease via inactivating p38MAPK pathway[J ] . Biochem Bioph Res Com, 2016, 474(2): 364-370. DOI: 10.1016/j.bbrc.2016. 04.111.

CHOI Y J, LEE K Y, JUNG S H, et al . Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice[J ] . Toxicol Appl Pharmacol, 2017, 316: 74-82. DOI: 10.1016/j.taap.2016.12.019.

NING C Q, GAO X G, WANG C Y, et al . Protective effects of ginsenoside Rg 1 against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice through inhibiting toll-like receptor 4 signaling pathway[J ] . Int Immunopharm, 2018, 61: 266-276. DOI: 10.1016/j.intimp.2018.06.008..

[徐雅姝, 黄文祥, 阳成, 等.人参皂苷Rg1对小鼠非酒精性脂肪肝的改善作用和机制研究[J/OL ] .重庆医科大学学报. [2019-05-31 ] . https://doi.org/10.13406/j.cnki.cyxb.001757 https://doi.org/10.13406/j.cnki.cyxb.001757 .

[XU Y S, HUANG W X, YANG C, et al . Effect of ginsenoside Rg1 against NAFLD in mice and its mechanism[J/OL ] . J Chongqing Med Univ.[2019-05-31 ] . https://doi.org/10.13406/j.cnki.cyxb.001757 https://doi.org/10.13406/j.cnki.cyxb.001757 ..

SINGH S, OSNA N A, KHARBANDA K K. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review[J]. World J Gastroenterol, 2017, 23(36): 6549-6570. DOI: 10.3748/wjg.v23.i36.6549.

桑婷婷, 郭铖洁, 郭丹丹, 等.中医药通过调节肠道菌群抑制肥胖和炎症相关疾病的进展研究[J].中国中药杂志, 2018, 43(16): 3235-3242. DOI:10.19540/j.cnki.cjcmm.20180423.003.

SANG T T, GUO C J, GUO D D, et al . Effect of traditional Chinese medicine in inhibiting obesity and inflammatory diseases by regulating gut microbiota[J ] . China J Chin Materia Medica, 2018, 43(16): 3235-3242. DOI:10.19540/j.cnki.cjcmm.20180423.003.

ZHAO J Q, SHI Z Y, LIU S, et al . Ginsenosides Rg 1 from panax ginseng: A potential therapy for acute liver failure patients?[J ] . Evid Based Complement Alternat Med, 2014, 2014: 538059. DOI: 10.1155/2014/538059..

LI J, YANG C, ZHANG S, et al . Ginsenoside Rg1 inhibits inflammatory responses via modulation of the nuclear factor-κB pathway and in hibition of inflammasome activation in alcoholic hepatitis[J ] . Int J Mol Med, 2018, 41(2): 899-907. DOI:10.3892/ijmm.2017.3297..

WOODS A, WILLIAMS J R, MUCKETT P J, et al . Liver-specific activation of AMPK prevents steatosis on a high-fructose diet[J ] . Cell Rep, 2017, 18(13): 3043-3051. DOI: 10.1016/j.celrep.2017.03.011.

NIGRO D, MENOTTI F, CENTO A S, et al . Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver[J ] . J Nutr Biochem, 2017, 42: 160-171. DOI: 10.1016/j.jnutbio.2017.01.010.

TIAN W, CHEN L, ZHANG L, et al . Effects of ginsenoside Rg 1 on glucose metabolism and liver injury in streptozotocin-induced type 2 diabetic rats[J ] . Genet Mol Res, 2017, 16(1). DOI: 10.4238/gmr16019463..

LI J B, ZHANG R, HAN X, et al . Ginsenoside Rg 1 inhibits dietary-induced obesity and improves obesity-related glucose metabolic disorders[J ] . Braz J Med Biol Res, 2018, 51(4): e7139. DOI: 10.1590/1414-431X20177139..

YAN Y, ZHOU X E, XU H E, et al . Structure and physiological regulation of AMPK[J ] . Int J Mol Sci, 2018, 19(11): E3534. DOI: 10.3390/ijms19113534.

KIM S J, YUAN H D, CHUNG S H.Ginsenoside Rg 1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells[J ] . Biol Pharm Bull, 2010, 33(2): 325-328..

SONG Y, KIM M B, KIM C, et al . 5, 7-dimethoxyflavone attenuates obesity by inhibiting adipogenesis in 3T3-L1 adipocytes and high-fat diet-induced obese C 57 BL/6J mice[J ] . J Med Food, 2016, 19(12): 1111-1119. DOI: 10.1089/jmf.2016.3800..

顾业芸, 周启程, 公欣华, 等.二氢山奈酚衍生物调控AMPK/PGC-1α通路抑制棕榈酸诱导的C2C12成肌分化细胞脂质沉积[J].第三军医大学学报, 2017, 39(16): 1606-1611. DOI:10.16016/j.1000-5404.201612097.

GU Y Y, ZHOU Q C, GONG X H, et al .Dihydrokaempferol derivatives inhibit palmitic acid-induced lipid deposition in C2C12 myotubes through AMPK/PGC-1a pathway[J ] . J Third Mil Med Univ, 2017, 39(16): 1606-1611. DOI:10.16016/j.1000-5404.201612097.

高燕翔, 张勇, 刘裕, 等. SREBP-1c在白藜芦醇预防大鼠非酒精性脂肪肝发生中的作用[J].第三军医大学学报, 2015, 37(17): 1704-1708. DOI:10.16016/j.1000-5404.201412125.

GAO Y X, ZHANG Y, LIU Y, et al . SREBP-lc is involved in preventive effect of resveratrol on pathogenesis of nonalcoholic fatty liver disease in rats[J ] . J Third Mil Med Univ, 2015, 37(17): 1704-1708. DOI:10.16016/j.1000-5404.201412125.

ZHONG J, GONG W Q, LU L, et al . Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db/db mice via stimulating PPAR-γ, AMPK/Akt/mTOR signaling and autophagy[J ] . Int Immunopharmacol, 2017, 42: 176-184. DOI: 10.1016/j.intimp.2016.11.015..

CORONA VELAZQUEZ A F, JACKSON W T. So many roads: the multifaceted regulation of autophagy induction[J]. Mol Cell Biol, 2018, 38(21). DOI: 10.1128/mcb.00303-18.

YANG P, LING L, SUN W J, et al . Ginsenoside Rg 1 inhibits apoptosis by increasing autophagy via the AMPK/mTOR signaling in serum deprivation macrophages[J ] . Acta Biochim Biophys Sin (Shanghai), 2018, 50(2): 144-155. DOI: 10.1093/abbs/gmx136..

LI Y J, WANG F, LUO Y.Ginsenoside Rg 1 protects against sepsis-associated encephalopathy through beclin 1-independent autophagy in mice[J ] . J Surg Res, 2017, 207: 181-189. DOI: 10.1016/j.jss.2016.08.080.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

紫檀芪调节PLIN5/FGF21通路抑制棕榈酸诱导的L6肌管细胞脂质沉积

三七三醇皂苷主要成分抑制剪切力诱导的血小板活化和聚集

牛磺石胆酸通过TGR5调节巨噬细胞极化改善肝细胞脂质沉积

人参皂苷Rg1对D-半乳糖所致小鼠心肌损伤的保护作用

人参皂苷Rg1促进移植大鼠的组织工程血管内皮化